Quantbot Technologies LP Buys 139,127 Shares of DENTSPLY SIRONA Inc. $XRAY

Key Points

• Quantbot Technologies LP increased its stake in DENTSPLY SIRONA Inc. by 51.0%, now owning approximately 411,976 shares valued at $6.15 million.
• Several hedge funds have also raised their positions in DENTSPLY SIRONA, with institutional investors now owning around 95.70% of the company's stock.
• The company recently reported quarterly earnings, exceeding analysts' expectations with $0.52 EPS and a revenue of $936 million, despite a 4.9% decline year-over-year.

Quantbot Technologies LP grew its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 51.0% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 411,976 shares of the medical instruments supplier's stock after purchasing an additional 139,127 shares during the quarter. Quantbot Technologies LP owned approximately 0.21% of DENTSPLY SIRONA worth $6,155,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in XRAY. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of DENTSPLY SIRONA during the 1st quarter valued at about $25,000. Colonial Trust Co SC bought a new position in shares of DENTSPLY SIRONA during the 4th quarter valued at approximately $26,000. Brooklyn Investment Group bought a new position in shares of DENTSPLY SIRONA during the 1st quarter valued at approximately $26,000. Caitong International Asset Management Co. Ltd grew its stake in shares of DENTSPLY SIRONA by 8,003.6% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier's stock valued at $34,000 after acquiring an additional 2,241 shares during the period. Finally, True Wealth Design LLC grew its stake in shares of DENTSPLY SIRONA by 866.7% during the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock valued at $41,000 after acquiring an additional 1,950 shares during the period. Hedge funds and other institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Trading Up 5.5%

NASDAQ:XRAY traded up $0.76 during midday trading on Friday, hitting $14.66. 2,284,098 shares of the company traded hands, compared to its average volume of 3,007,447. The firm's fifty day moving average is $15.29 and its 200-day moving average is $15.55. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $27.48. The firm has a market capitalization of $2.92 billion, a P/E ratio of -3.09, a P/E/G ratio of 0.89 and a beta of 0.94. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The company had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. During the same quarter in the prior year, the firm posted $0.49 EPS. DENTSPLY SIRONA's quarterly revenue was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.4%. DENTSPLY SIRONA's dividend payout ratio is presently -13.50%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on XRAY shares. Piper Sandler cut their price objective on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Wall Street Zen downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. UBS Group cut their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Finally, Barrington Research cut their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a research note on Friday, August 8th. Two analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company's stock. According to data from MarketBeat, DENTSPLY SIRONA currently has an average rating of "Hold" and an average price target of $18.64.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.